Lithium Americas Corp vs Sana Biotechnology Inc — how do they compare? Lithium Americas Corp trades at $3.06 (market cap $1.01B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Lithium Americas Corp is the larger of the two by market cap. Which is the better fit depends on your goals.
| LAC | SANA | |
|---|---|---|
Market Cap | $1.01B | $873.84M |
Sector | Basic Materials | Health |
52-Week High | $10.05 | $5.92 |
52-Week Low | $2.55 | $2.68 |
Enterprise Value | $1.13B | $848.03M |
Trailing returns across standard periods
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →